OSTEOARTHRITIS
Autologous conditioned serum effective in knee osteoarthritis vs. hyaluronan or saline
Osteoarthritis Cartilage. 2009 Feb;17(2):152-60376 patients diagnosed with chronic primary knee osteoarthritis were randomized to receive autologous conditioned serum, hyaluronan, or saline injections. The purpose of this study was to compare the clinical efficacy and safety of autologous conditioned serum to the other treatments. Significantly greater improvements were displayed by the autologous conditioned serum group in terms of WOMAC, VAS pain, and SF-8 HRQL scores at weeks 7, 13, and 26 and in global patient assessment of treatment efficacy at 13 and 26 weeks, compared to the other two groups. Overall adverse events were significantly lower in the autologous conditioned serum and saline groups and the additional 2-year follow-up was consistent with the previous quality of life and clinical outcome results.
Unlock the full ACE Report
You have access to {0} free articles per month.Click below to unlock and view this {1}
Unlock NowCritical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
Or upgrade today and gain access to all OrthoEvidence content for just $1.99 per week.
Already have an account? Log in
Subscribe to "The Pulse"
Evidence-Based Orthopaedics direct to your inbox.
{0} of {1} free articles
Become an OrthoEvidence Premium Member. Expand your perspective with high-quality evidence.
Upgrade Now
